WA1
CVS icon

Wimmer Associates 1’s CVS Health CVS Stock Holding History

Wimmer Associates 1’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,705
Closed -$216K – 110
2024
Q1 		$216K Sell
2,705
-160
-6% -$12.2K 0.11% 108
2023
Q4 		$226K Sell
2,865
-185
-6% -$13.2K 0.13% 106
2023
Q3 		$213K Hold
3,050
– – 0.13% 105
2023
Q2 		$211K Hold
3,050
– – 0.13% 105
2023
Q1 		$210K Buy
3,050
+50
+2% +$4.19K 0.13% 105
2022
Q4 		$280K Sell
3,000
-130
-4% -$12.5K 0.18% 95
2022
Q3 		$296K Hold
3,130
– – 0.2% 91
2022
Q2 		$290K Sell
3,130
-100
-3% -$9.76K 0.19% 95
2022
Q1 		$327K Buy
3,230
+465
+17% +$48.8K 0.18% 96
2021
Q4 		$285K Sell
2,765
-65
-2% -$6.01K 0.15% 102
2021
Q3 		$240K Buy
2,830
+195
+7% +$16.3K 0.14% 110
2021
Q2 		$220K Buy
+2,635
New +$216K 0.13% 115
2018
Q2 		– Sell
-6,395
Closed -$398K – 105
2018
Q1 		$398K Buy
6,395
+2
+0% +$143 0.35% 77
2017
Q4 		$464K Sell
6,393
-7,524
-54% -$547K 0.42% 69
2017
Q3 		$1.13M Sell
13,917
-299
-2% -$23.7K 1.04% 41
2017
Q2 		$1.14M Sell
14,216
-39
-0.3% -$3.08K 1.05% 38
2017
Q1 		$1.12M Buy
14,255
+252
+2% +$20.1K 1.05% 37
2016
Q4 		$1.1M Sell
14,003
-3,855
-22% -$312K 1.02% 38
2016
Q3 		$1.59M Buy
17,858
+876
+5% +$82.7K 1.43% 25
2016
Q2 		$1.63M Buy
16,982
+245
+1% +$24.4K 1.45% 24
2016
Q1 		$1.74M Buy
16,737
+1,450
+9% +$141K 1.59% 20
2015
Q4 		$1.5M Buy
+15,287
New +$1.5M 1.57% 21

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wimmer Associates 1's CVS Position: Q2 2024 in Review

Wimmer Associates 1 sold out of CVS Health (CVS) in Q2 2024, closing a stake of 2,705 shares — an estimated $216K sold.

Wimmer Associates 1 first reported a position in CVS in Q4 2015 and held it in 22 quarters. The position peaked at $1.74M in Q1 2016. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Wimmer Associates 1 reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Wimmer Associates 1 sold 2,705 CVS Health shares in Q2 2024, an estimated $216K.
  • Wimmer Associates 1 first reported a position in CVS Health in Q4 2015 and held it in 22 quarters.
  • Wimmer Associates 1's CVS Health position peaked at $1.74M in Q1 2016.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Wimmer Associates 1's 13F filing for Q2 2024, filed 13 Aug 2024.